These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Intracerebroventricular infusion of dopamine and its agonists in rodents and primates. An experimental approach to the treatment of Parkinson's disease. Garcia de Yebenes J, Fahn S, Mena MA, Pardo B, Casarejos MJ. ASAIO Trans; 1988; 34(4):951-7. PubMed ID: 2905893 [Abstract] [Full Text] [Related]
5. Antiparkinsonian activity of (+)-PHNO in the MPTP-treated common marmoset. Nomoto M, Stahl S, Jenner P, Marsden CD. Mov Disord; 1987; 2(1):37-45. PubMed ID: 2904119 [Abstract] [Full Text] [Related]
8. Intracerebroventricular infusion of (+)-4-propyl-9-hydroxy-naphthoxacine in monkeys with MPTP-induced akinesia. de Yébenes JG, Fahn S, Goodman R, Jamrosik Z, Pezzoli G, Popalski S. Adv Neurol; 1990; 53():231-8. PubMed ID: 1978516 [No Abstract] [Full Text] [Related]
9. Behavioral differences in a rotenone-induced hemiparkinsonian rat model developed following intranigral or median forebrain bundle infusion. Sindhu KM, Saravanan KS, Mohanakumar KP. Brain Res; 2005 Jul 27; 1051(1-2):25-34. PubMed ID: 15992782 [Abstract] [Full Text] [Related]
12. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system. Galineau L, Wilson AA, Garcia A, Houle S, Kapur S, Ginovart N. Synapse; 2006 Aug 27; 60(2):172-83. PubMed ID: 16715499 [Abstract] [Full Text] [Related]
13. Intrastriatal infusion of liver growth factor stimulates dopamine terminal sprouting and partially restores motor function in 6-hydroxydopamine-lesioned rats. Reimers D, Herranz AS, Díaz-Gil JJ, Lobo MV, Paíno CL, Alonso R, Asensio MJ, Gonzalo-Gobernado R, Bazán E. J Histochem Cytochem; 2006 Apr 27; 54(4):457-65. PubMed ID: 16344326 [Abstract] [Full Text] [Related]
14. Intraventricular infusion of epidermal growth factor restores dopaminergic pathway in hemiparkinsonian rats. Pezzoli G, Zecchinelli A, Ricciardi S, Burke RE, Fahn S, Scarlato G, Carenzi A. Mov Disord; 1991 Apr 27; 6(4):281-7. PubMed ID: 1684638 [Abstract] [Full Text] [Related]
15. Dopamine D1 and D2 receptor-mediated acute and long-lasting behavioral effects of glial cell line-derived neurotrophic factor administered into the striatum. Kobayashi S, Ogren SO, Hoffer BJ, Olson L. Exp Neurol; 1998 Dec 27; 154(2):302-14. PubMed ID: 9878169 [Abstract] [Full Text] [Related]
16. Effects of paraquat on the substantia nigra of the wistar rats: neurochemical, histological, and behavioral studies. Liou HH, Chen RC, Tsai YF, Chen WP, Chang YC, Tsai MC. Toxicol Appl Pharmacol; 1996 Mar 27; 137(1):34-41. PubMed ID: 8607139 [Abstract] [Full Text] [Related]
17. Intrastriatal infusion of lisuride--a potential treatment for Parkinson's disease? Behavioral and autoradiographic studies in 6-OHDA lesioned rats. May CH, Guilarte TR, Wagner HN, Vogel S. Neurodegeneration; 1994 Dec 27; 3(4):305-13. PubMed ID: 7842301 [Abstract] [Full Text] [Related]
18. Reductions in spontaneous locomotor activity in aged male, but not female, rats in a model of early Parkinson's disease. Cass WA, Peters LE, Smith MP. Brain Res; 2005 Feb 09; 1034(1-2):153-61. PubMed ID: 15713267 [Abstract] [Full Text] [Related]
20. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats. Lorenc-Koci E, Antkiewicz-Michaluk L, Kamińska A, Lenda T, Zieba B, Wierońska J, Smiałowska M, Schulze G, Rommelspacher H. Neuroscience; 2008 Oct 28; 156(4):973-86. PubMed ID: 18809471 [Abstract] [Full Text] [Related] Page: [Next] [New Search]